Investing

Jeffrey Christian: Gold, Silver and “Another Year of Living Dangerously”

Speaking at this year’s Prospectors & Developers Association of Canada (PDAC) convention, Jeffrey Christian, managing partner at CPM Group, shared his outlook for gold and silver prices moving forward.

‘We’re looking for record gold prices (in 2024) … we’re looking for a significant, in our mind, increase in gold prices,’ he said. ‘We’re looking at an average price of maybe US$2,050 (per ounce), up from US$1,950 last year.’

Christian sees more of a move happening in the third and fourth quarters as worries increase among investors.

In terms of silver, Christian said CPM Group thinks US$20 to US$22 per ounce will be its low range for the year, while US$27 or US$28 will be its high point. As with gold, the firm expects the silver price to pick up toward the end of 2024.

All in all, he sees 2024 as ‘another year of living dangerously’ — a phrase CPM Group last used to describe 2008.

‘We look at 2024, 2025 as a similar period of uncertainty,’ he noted. ‘I think one of the big parallels is you’re looking at a year in 2024 where politics will be much more important in investors deciding whether to buy or sell gold and silver.’

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

You May Also Like

Investing

2023 was a relatively lackluster year, silver largely traded on volatility between US$22 and US$25 per ounce. The white metal started 2024 with less...

Latest News

Dong’s experience, both as head of the People’s Liberation Army Navy (PLAN) as well as operational assignments in the Chinese military’s Eastern and Southern...

Investing

The US was one of the world’s top silver producers in 2023, recording output of 1,000 metric tons (MT). While that’s far below first-place...

Investing

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription drug market. But what...

Disclaimer: GreatWallStreetPublisher.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 GreatWallStreetPublisher.com

Exit mobile version